AtriCure, Inc. (ATRC) Free cash flow 2016–2025
AtriCure, Inc. (ATRC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$48.3MFY2025 · since FY2016: -$22.8M → $48.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $48.3M | +6381.1% |
| FY2024 | $745,000 | +109.9% |
| FY2023 | -$7.5M | +80.7% |
| FY2022 | -$39.0M | -65.8% |
| FY2021 | -$23.5M | +6.3% |
| FY2020 | -$25.1M | +10.2% |
| FY2019 | -$28.0M | -169.6% |
| FY2018 | -$10.4M | +32.3% |
| FY2017 | -$15.3M | +32.8% |
| FY2016 | -$22.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice